A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Eisai Inc.
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
Udayana University
Ezisurg Medical Co. Ltd.
Bayer
University of Florida
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Sanofi
Sanofi
National Taiwan University Hospital
Centre Francois Baclesse
Memorial Sloan Kettering Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Washington University School of Medicine
Sichuan Enray Pharmaceutical Sciences Company
Medical College of Wisconsin
Fudan University
University Medical Center Groningen
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
TransThera Sciences (Nanjing), Inc.
Stanford University
Hoffmann-La Roche
Mayo Clinic
Seoul National University Hospital
Alume Biosciences, Inc.
Thomas Jefferson University
The First Affiliated Hospital of Zhengzhou University
Osaka University
University of Foggia
The First Affiliated Hospital of Xiamen University
Vastra Gotaland Region
National Cancer Institute (NCI)
Aristotle University Of Thessaloniki